本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Eledon Pharmaceuticals, Inc.

3.10
0.0000
盤後3.130.0300+0.97%19:27 EDT
成交量:97.11萬
成交額:301.28萬
市值:2.35億
市盈率:-5.57
高:3.18
開:3.10
低:3.07
收:3.10
52周最高:4.60
52周最低:1.35
股本:7,585.17萬
流通股本:6,858.32萬
量比:0.80
換手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):-0.5566
每股收益(LYR):-0.5566
淨資產收益率:-35.79%
總資產收益率:-30.04%
市淨率:1.72
市盈率(LYR):-5.57

資料載入中...

2021/01/07

重要事件披露

8-K - Current report
2021/01/05

重要事件披露

8-K - Current report
2021/01/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/30

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/28

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/22

重要事件披露

8-K - Current report
2020/12/17

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/10

重要事件披露

8-K - Current report
2020/12/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/20

重要事件披露

8-K/A [Amend] - Current report
2020/11/20

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/20

重要事件披露

8-K - Current report
2020/11/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/06

重要事件披露

8-K - Current report
2020/10/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals